Pains wrought by the sequestration of the US federal budget have already begun to put the hurt on biomedical and genomics research communities, as had been predicted, but also it is directly affecting cancer clinics and patients, which was not expected.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Genomics' Hot Streak

A Dollop More

Ounce of Prevention

Make It a Double

Between Two Worlds

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.